Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Toxicology Launches Mitragynine ELISA

Published: Friday, April 12, 2013
Last Updated: Friday, April 12, 2013
Bookmark and Share
New ELISA for the detection of designer drug Kratom.

Kratom is a designer drug which originates from Mitragyna speciosa; an uncontrolled plant found in South East Asia.

The designer drug has gained significant popularity in recent years due to its widespread availability on the internet and in head shops.

It is marketed as a way to combat fatigue, pain and depression. The new ELISA developed by Randox Toxicology is the world’s first immunoassay drug test for Kratom; providing a rapid solution for the detection of Mitragynine and its metabolites.

As with other designer drugs ‘Spice’ and ‘Bath Salts,’ ‘Kratom’ is marketed as a “legal high,” which can mislead users to believe that the drug is safe to use.

In fact, several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion.

Mitragynine and several related alkaloids naturally occur in the Mitragyna speciosa plant, creating psychoactive properties.

From exotic plants to synthetic blends; designer drugs create a difficult task for forensic toxicologists as waves of new compounds with differing chemical properties quickly flood the market.

Immunoassays provide a straightforward method for laboratory drug screening, allowing a large number of specimens can be screened relatively quickly.

The novel ELISA developed by Randox Toxicology can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.

Leading research and development capabilities has allowed Randox Toxicology to quickly respond to the need for reliable assays to detect designer drugs.

The UK manufacturer has developed a range of rapid immunoassays on ELISA and Biochip arrays, including Synthetic Cannabinoids and Synthetic Cathinones commonly referred to as ‘Bath Salts.’


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immune-Cell Traps May Aid Cancer Metastasis
Study suggests cancer cells can induce neutrophils to release traps which the cells use to capture pathogens.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
New Regulator of Immune Reaction Discovered
Calcium signal in cell nucleus regulates not only many brain functions but also defence reactions of the immune system.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Cell’s ‘Built-In Circuit’ Help Prevent Tumour Growth
Researchers have created cells with a 'built-in genetic circuit' that inhibits tumour growth.
Factors Behind Suppression of Stem Cell Mobilization Revealed
The findings could lead to improvements in transplantation therapy.
Common Virus Helps Fight Liver Cancer
Reovirus, a cause of childhood colds, stimulates the immune system to kill cancerous cells.
Antibody Protects Mice from Zika Infection
Researchers develop human-derived antibody protected pregnant mice and their developing fetuses from Zika infection.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!